ベルギー肺機能研究 (AIRCAST)
ベルギー肺機能研究:疾患進行のマーカーとしての個別化縦断的肺機能解析
Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns.
A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.
調査の概要
状態
条件
詳細な説明
The objective of this study is to explore the clinical value of models predicting longitudinal lung function patterns in individuals with chronic respiratory diseases across Belgium.
- The investigators will assess the accuracy of individualised lung function prediction models in a multicentre lung function dataset with prospective clinical and lung function follow-up.
- The investigators will evaluate important health outcomes, step-up in care, patient-reported outcomes in individuals identified with an expected and unexpected observed trajectory as compared to the predicted population and individualised trajectory.
The hypothesis is that patients with an unexpected decline in lung function will have worse health outcomes, such as a higher mortality rate and more hospitalisations, compared to patients with an expected lung function pattern. The investigators hypothesise to observe better health outcomes and lower mortality rates in patients with an unexpectedly positive lung function evolution compared to patients with an expected negative lung function pattern.
Individuals will be recruited from 4 Belgian Hospitals (UZ Leuven, UZ Antwerpen, AZ Delta, ZOL Genk). Based on the annual rate of pulmonary function testing in these hospitals, a sample size of 1.000 participants per centre is anticipated within one year of inclusions, resulting in a total sample size of 4.000 patients.
All available historical lung function data of included individuals will be retrieved from the individuals medical file. Additionally, the individual will be prospectively followed for 2 years where all lung function data will be collected.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Marieke Wuyts
- 電話番号:016 34 31 59
- メール:marieke.wuyts@kuleuven.be
研究場所
-
-
-
Edegem、ベルギー、2650
- 募集
- UZ Antwerpen
-
コンタクト:
- Therese Lapperre
- 電話番号:0032 3 821 5089
- メール:therese.lapperre@uza.be
-
主任研究者:
- Therese Lapperre
-
副調査官:
- Kevin De Soomer
-
Genk、ベルギー、3600
- 募集
- Ziekenhuis Oost-Limburg
-
コンタクト:
- David Ruttens
- 電話番号:0032 89 80 52 00
- メール:david.ruttens@zol.be
-
主任研究者:
- David Ruttens
-
副調査官:
- Maarten Criel
-
Ghent、ベルギー
- 募集
- UZ Gent
-
主任研究者:
- Eric Derom
-
コンタクト:
- Eric Derom
- 電話番号:0032 9 332 23 42
- メール:Eric.Derom@uzgent.be
-
副調査官:
- Lies Lahousse
-
Leuven、ベルギー、3000
- 募集
- UZ Leuven
-
主任研究者:
- Wim Janssens
-
コンタクト:
- Marieke Wuyts
- 電話番号:016 34 31 59
- メール:marieke.wuyts@kuleuvne.be
-
Roeselare、ベルギー、8800
- 募集
- AZ Delta
-
主任研究者:
- Ingel Demedts
-
コンタクト:
- Ingel Demedts
- 電話番号:0032 51 23 41 16
- メール:ingel.demedts@azdelta.be
-
副調査官:
- Bernard Bouckaert
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Chronic respiratory diseases
説明
Inclusion Criteria:
- Above 18 years old
- Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals
- Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline
- Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion
- Planned routine follow-up within standard clinical care in one of the participating hospitals
Exclusion Criteria:
- Patients who have had a lung transplantation
- Patients not being able to give consent to participate
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Accuracy of lung function predictions (FEV1)
時間枠:at 1 and 2-year follow-up
|
Proportion of correct and incorrect FEV1 predictions compared to the observed measure |
at 1 and 2-year follow-up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Differences in clinical outcomes between correct and incorrect lung function predictions (FEV1)
時間枠:at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FEV1 on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care |
at 1 and 2-year follow-up
|
|
Accuracy of lung function predictions
時間枠:at 1 and 2-year follow-up
|
Proportion of correct and incorrect lung function predictions (FVC, TLC, RV/TLC, DLCO) compared to the observed measure |
at 1 and 2-year follow-up
|
|
Differences in clinical outcomes between correct and incorrect lung function predictions
時間枠:at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FVC, TLC, RV/TLC, DLCO on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care) |
at 1 and 2-year follow-up
|
|
Identifying the minimal needed to make predictions
時間枠:after 2 years
|
Minimal number of tests/length of follow-up required for optimal predictions |
after 2 years
|
|
Performance of ML-based predictions compared to linear regression analysis
時間枠:at 1 and 2-year follow-up
|
Comparison of the ML-based predictions for individual and population lung function changes with predictions based on linear regression on individual historical data |
at 1 and 2-year follow-up
|
|
Overall description of population
時間枠:baseline, 1 and 2-year follow-up
|
Sociodemographic information, health status, comorbidities, frailty, disease labels, interventions and prognosis of individuals with a chronic respiratory disease |
baseline, 1 and 2-year follow-up
|
協力者と研究者
スポンサー
協力者
捜査官
- 主任研究者:Wim Janssens、UZ/KU Leuven
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。